newsfilter
← Latest News
Business Wire·

Forma Therapeutics to Report Third Quarter 2021 Financial Results and Provide Business Update on November 12, 2021

Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX), a clinical-stage biopharmaceutical company focused on sickle cell disease, prostate cancer and other rare hematologic diseases and cancers, today announced that it will release third quarter 2021 fi